A Retrospective Cohort Study to Assess Drug Utilisation and Long-Term Safety of Galcanezumab in US Patients in the Course of Routine Clinical Care (I5Q-MC-B001)

17/01/2019
03/02/2026
EU PAS number:
EUPAS27597
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

I5Q-MC-B001 Protocol v1_Redacted

English (735 KB - PDF) View document
Updated protocol

LY2951742 B001 Protocol Amendment (c)_Redacted.pdf

First published: 03/02/2026
English (1.04 MB - PDF) View document

I5Q-MC-B001_Galcanezumab_US_LongTermSafety_Protocol_Amend(b)_Redacted

First published: 22/02/2024
English (804.54 KB - PDF) View document
Study results
Study report
Other information